Novel Infrastructure for Sepsis Biomarker Research in Critically Ill Neonates and Children

Justin E. Juskewitch, Felicity T Enders, Roshini S. Abraham, W Charles Huskins

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction: Sepsis biomarker research requires an infrastructure to identify septic patients efficiently and to collect and store specimens properly. We developed a novel infrastructure to study biomarkers of sepsis in children. Methods: Patients in pediatric and neonatal intensive care units were enrolled prospectively; enrollment information was stored in a secure, remotely accessible database. Researchers were notified of electronic medical record (EMR) orders for blood cultures (a surrogate for a diagnostic evaluation of suspected sepsis) by a page triggered by the order. Staff confirmed patient enrollment and remotely submitted an EMR order for collection of study specimens simultaneous with the blood culture. Specimens were processed and stored by a mobile clinical research unit. Results: Over 2 years, 2029 patients were admitted; 138 were enrolled. Staff received pages for 95% of blood cultures collected from enrolled patients. The median time between the blood culture order and collection was 34 minutes (range 9-241). Study specimens were collected simultaneously with 41 blood cultures. The median times between specimen collection and storage for flow cytometry and cytokine analysis were 33 minutes (range 0-82) and 52 minutes (range 28-98), respectively. Conclusion: This novel infrastructure facilitated prompt, proper collection and storage of specimens for sepsis biomarker analysis.

Original languageEnglish (US)
Pages (from-to)21-25
Number of pages5
JournalClinical and Translational Science
Volume6
Issue number1
DOIs
StatePublished - Feb 2013

Fingerprint

Biomarkers
Critical Illness
Sepsis
Specimen Handling
Blood
Newborn Infant
Electronic medical equipment
Research
Electronic Health Records
Intensive care units
Pediatric Intensive Care Units
Pediatrics
Flow cytometry
Neonatal Intensive Care Units
Flow Cytometry
Research Personnel
Blood Culture
Databases
Cytokines

Keywords

  • Pediatric intensive care units
  • Sepsis
  • Systemic inflammatory response syndrome
  • Translational medical research

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Novel Infrastructure for Sepsis Biomarker Research in Critically Ill Neonates and Children. / Juskewitch, Justin E.; Enders, Felicity T; Abraham, Roshini S.; Huskins, W Charles.

In: Clinical and Translational Science, Vol. 6, No. 1, 02.2013, p. 21-25.

Research output: Contribution to journalArticle

@article{411182f74b3b4592b31bb5e7d26a7ff0,
title = "Novel Infrastructure for Sepsis Biomarker Research in Critically Ill Neonates and Children",
abstract = "Introduction: Sepsis biomarker research requires an infrastructure to identify septic patients efficiently and to collect and store specimens properly. We developed a novel infrastructure to study biomarkers of sepsis in children. Methods: Patients in pediatric and neonatal intensive care units were enrolled prospectively; enrollment information was stored in a secure, remotely accessible database. Researchers were notified of electronic medical record (EMR) orders for blood cultures (a surrogate for a diagnostic evaluation of suspected sepsis) by a page triggered by the order. Staff confirmed patient enrollment and remotely submitted an EMR order for collection of study specimens simultaneous with the blood culture. Specimens were processed and stored by a mobile clinical research unit. Results: Over 2 years, 2029 patients were admitted; 138 were enrolled. Staff received pages for 95{\%} of blood cultures collected from enrolled patients. The median time between the blood culture order and collection was 34 minutes (range 9-241). Study specimens were collected simultaneously with 41 blood cultures. The median times between specimen collection and storage for flow cytometry and cytokine analysis were 33 minutes (range 0-82) and 52 minutes (range 28-98), respectively. Conclusion: This novel infrastructure facilitated prompt, proper collection and storage of specimens for sepsis biomarker analysis.",
keywords = "Pediatric intensive care units, Sepsis, Systemic inflammatory response syndrome, Translational medical research",
author = "Juskewitch, {Justin E.} and Enders, {Felicity T} and Abraham, {Roshini S.} and Huskins, {W Charles}",
year = "2013",
month = "2",
doi = "10.1111/cts.12025",
language = "English (US)",
volume = "6",
pages = "21--25",
journal = "Clinical and Translational Science",
issn = "1752-8054",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Novel Infrastructure for Sepsis Biomarker Research in Critically Ill Neonates and Children

AU - Juskewitch, Justin E.

AU - Enders, Felicity T

AU - Abraham, Roshini S.

AU - Huskins, W Charles

PY - 2013/2

Y1 - 2013/2

N2 - Introduction: Sepsis biomarker research requires an infrastructure to identify septic patients efficiently and to collect and store specimens properly. We developed a novel infrastructure to study biomarkers of sepsis in children. Methods: Patients in pediatric and neonatal intensive care units were enrolled prospectively; enrollment information was stored in a secure, remotely accessible database. Researchers were notified of electronic medical record (EMR) orders for blood cultures (a surrogate for a diagnostic evaluation of suspected sepsis) by a page triggered by the order. Staff confirmed patient enrollment and remotely submitted an EMR order for collection of study specimens simultaneous with the blood culture. Specimens were processed and stored by a mobile clinical research unit. Results: Over 2 years, 2029 patients were admitted; 138 were enrolled. Staff received pages for 95% of blood cultures collected from enrolled patients. The median time between the blood culture order and collection was 34 minutes (range 9-241). Study specimens were collected simultaneously with 41 blood cultures. The median times between specimen collection and storage for flow cytometry and cytokine analysis were 33 minutes (range 0-82) and 52 minutes (range 28-98), respectively. Conclusion: This novel infrastructure facilitated prompt, proper collection and storage of specimens for sepsis biomarker analysis.

AB - Introduction: Sepsis biomarker research requires an infrastructure to identify septic patients efficiently and to collect and store specimens properly. We developed a novel infrastructure to study biomarkers of sepsis in children. Methods: Patients in pediatric and neonatal intensive care units were enrolled prospectively; enrollment information was stored in a secure, remotely accessible database. Researchers were notified of electronic medical record (EMR) orders for blood cultures (a surrogate for a diagnostic evaluation of suspected sepsis) by a page triggered by the order. Staff confirmed patient enrollment and remotely submitted an EMR order for collection of study specimens simultaneous with the blood culture. Specimens were processed and stored by a mobile clinical research unit. Results: Over 2 years, 2029 patients were admitted; 138 were enrolled. Staff received pages for 95% of blood cultures collected from enrolled patients. The median time between the blood culture order and collection was 34 minutes (range 9-241). Study specimens were collected simultaneously with 41 blood cultures. The median times between specimen collection and storage for flow cytometry and cytokine analysis were 33 minutes (range 0-82) and 52 minutes (range 28-98), respectively. Conclusion: This novel infrastructure facilitated prompt, proper collection and storage of specimens for sepsis biomarker analysis.

KW - Pediatric intensive care units

KW - Sepsis

KW - Systemic inflammatory response syndrome

KW - Translational medical research

UR - http://www.scopus.com/inward/record.url?scp=84873706835&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873706835&partnerID=8YFLogxK

U2 - 10.1111/cts.12025

DO - 10.1111/cts.12025

M3 - Article

VL - 6

SP - 21

EP - 25

JO - Clinical and Translational Science

JF - Clinical and Translational Science

SN - 1752-8054

IS - 1

ER -